Surgical Outcomes of Laparoscopic Right Colectomy with Complete Mesocolic Excision.
Adenocarcinoma
/ surgery
Adult
Aged
Aged, 80 and over
Colectomy
/ methods
Colonic Neoplasms
/ surgery
Female
Humans
Laparoscopy
/ methods
Length of Stay
Male
Mesocolon
/ surgery
Middle Aged
Minimally Invasive Surgical Procedures
Operative Time
Peritoneal Neoplasms
/ surgery
Postoperative Complications
/ etiology
Retrospective Studies
Robotic Surgical Procedures
/ methods
Treatment Outcome
Central Vascular Ligation
Colorectal cancer
Complete Mesocolic Excision
Laparoscopic right colectomy
Laparoscopy
Journal
JSLS : Journal of the Society of Laparoendoscopic Surgeons
ISSN: 1938-3797
Titre abrégé: JSLS
Pays: United States
ID NLM: 100884618
Informations de publication
Date de publication:
Historique:
entrez:
11
6
2020
pubmed:
11
6
2020
medline:
13
11
2020
Statut:
ppublish
Résumé
Literature demonstrates that colorectal cancer is nowadays one of the most common malignancies. Laparoscopy and robotic surgery are progressively gaining popularity in the treatment of colorectal tumors. Complete mesocolic excision and central vascular ligation have been widely adopted with encouraging results in terms of an improvement of overall survival, but some studies in the literature seem to demonstrate a higher morbidity rate. We conducted a retrospective study from 01/01/2010 to 30/04/2019 on a series of 250 patients, 155 males (62%) and 95 females (38%) who underwent right colectomy with minimally invasive approach, complete mesocolic excision, central vascular ligation, and intracorporeal anastomosis. No perioperative mortality occurred. Postoperative morbidity rate was 6%, including 10 cases of anastomotic leak (5%). Conversion rate was 2.5%. Mean hospital stay was 6 days (range, 4-25 days). Mean operative time was 70 minutes (range, 50-130 minutes). No cases of duodenal or pancreatic damages, no chronic pain or diarrhea, and no severe alteration of bowel function were recorded. We observed only 3 cases of transient delayed gastric emptying. Laparoscopic right colectomy with complete mesocolic excision, central vascular ligation and intracorporeal anastomosis leads to encouraging oncological mid- and long-term outcomes with low complications rates.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Literature demonstrates that colorectal cancer is nowadays one of the most common malignancies. Laparoscopy and robotic surgery are progressively gaining popularity in the treatment of colorectal tumors. Complete mesocolic excision and central vascular ligation have been widely adopted with encouraging results in terms of an improvement of overall survival, but some studies in the literature seem to demonstrate a higher morbidity rate.
METHODS
METHODS
We conducted a retrospective study from 01/01/2010 to 30/04/2019 on a series of 250 patients, 155 males (62%) and 95 females (38%) who underwent right colectomy with minimally invasive approach, complete mesocolic excision, central vascular ligation, and intracorporeal anastomosis.
RESULTS
RESULTS
No perioperative mortality occurred. Postoperative morbidity rate was 6%, including 10 cases of anastomotic leak (5%). Conversion rate was 2.5%. Mean hospital stay was 6 days (range, 4-25 days). Mean operative time was 70 minutes (range, 50-130 minutes). No cases of duodenal or pancreatic damages, no chronic pain or diarrhea, and no severe alteration of bowel function were recorded. We observed only 3 cases of transient delayed gastric emptying.
CONCLUSIONS
CONCLUSIONS
Laparoscopic right colectomy with complete mesocolic excision, central vascular ligation and intracorporeal anastomosis leads to encouraging oncological mid- and long-term outcomes with low complications rates.
Identifiants
pubmed: 32518478
doi: 10.4293/JSLS.2020.00023
pii: JSLS.2020.00023
pmc: PMC7242021
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2020 by JSLS, Journal of the Society of Laparoscopic & Robotic Surgeons.
Références
Surg Endosc. 2020 Feb;34(2):610-621
pubmed: 31089882
Eur J Surg Oncol. 2005 Oct;31(8):845-53
pubmed: 15979269
Crit Rev Oncol Hematol. 2016 Dec;108:154-163
pubmed: 27931834
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
N Engl J Med. 2004 Jun 3;350(23):2343-51
pubmed: 15175436
Lancet Oncol. 2015 Feb;16(2):161-8
pubmed: 25555421
World J Surg Oncol. 2018 Oct 30;16(1):214
pubmed: 30376849
Int J Colorectal Dis. 2014 Apr;29(4):419-28
pubmed: 24477788
Langenbecks Arch Surg. 2017 May;402(3):417-427
pubmed: 27595589
World J Surg Oncol. 2018 Jun 28;16(1):117
pubmed: 29954404
Cancer. 2006 Oct 1;107(7):1624-33
pubmed: 16933324
Discov Med. 2010 Apr;9(47):328-36
pubmed: 20423677
Int J Colorectal Dis. 2016 Sep;31(9):1577-94
pubmed: 27469525
Int J Colorectal Dis. 2013 Sep;28(9):1177-86
pubmed: 23371336
Dis Colon Rectum. 2018 Sep;61(9):1063-1072
pubmed: 30086055
PLoS One. 2018 Oct 24;13(10):e0206277
pubmed: 30356298
Int J Surg. 2016 Mar;27:151-157
pubmed: 26850326
Dan Med Bull. 2010 Dec;57(12):A4224
pubmed: 21122462